These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2294819)

  • 61. Passive immunization for infection with Haemophilus influenzae type b.
    Santosham M; Reid R; Letson GW; Wolff MC; Siber G
    Pediatrics; 1990 Apr; 85(4 Pt 2):662-6. PubMed ID: 2179857
    [TBL] [Abstract][Full Text] [Related]  

  • 62. From the Centers for Disease Control and Prevention. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
    JAMA; 1993 May; 269(18):2359. PubMed ID: 8479054
    [No Abstract]   [Full Text] [Related]  

  • 63. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
    Vella PP; Ellis RW
    Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Haemophilus Influenzae Vaccine Efficacy Study Group.
    Wenger JD; Pierce R; Deaver KA; Plikaytis BD; Facklam RR; Broome CV
    Lancet; 1991 Aug; 338(8764):395-8. PubMed ID: 1678080
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibody persistence after accelerated immunisation against Haemophilus influenzae type b.
    Booy R; Hodgson S; Griffiths H; Chapel HM; Moxon ER
    BMJ; 1993 Apr; 306(6883):971-2. PubMed ID: 8490473
    [No Abstract]   [Full Text] [Related]  

  • 68. Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease.
    Siber GR; Gorham C; Martin P; Corkery JC; Schiffman G
    Ann Intern Med; 1986 Apr; 104(4):467-75. PubMed ID: 3082268
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunodeficiency associated with recurrent infections and an isolated in vivo inability to respond to bacterial polysaccharides.
    Gigliotti F; Herrod HG; Kalwinsky DK; Insel RA
    Pediatr Infect Dis J; 1988 Jun; 7(6):417-20. PubMed ID: 3393402
    [No Abstract]   [Full Text] [Related]  

  • 70. New Haemophilus influenzae vaccine licensed.
    Marwick C
    JAMA; 1988 Feb; 259(5):643, 647. PubMed ID: 3257280
    [No Abstract]   [Full Text] [Related]  

  • 71. Haemophilus influenzae type b vaccination.
    Herceg A
    Med J Aust; 1993 Jul; 159(1):70. PubMed ID: 8316135
    [No Abstract]   [Full Text] [Related]  

  • 72. Evaluation of pilus vaccines for prevention of experimental otitis media caused by nontypable Haemophilus influenzae.
    Karasic RB; Beste DJ; To SC; Doyle WJ; Wood SW; Carter MJ; To AC; Tanpowpong K; Bluestone CD; Brinton CC
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S62-5. PubMed ID: 2564659
    [No Abstract]   [Full Text] [Related]  

  • 73. Improved prophylaxis against overwhelming postsplenectomy infections.
    Germing U; Gaigounidis A; Schneider W
    Eur J Haematol; 1997 Nov; 59(5):329-30. PubMed ID: 9414646
    [No Abstract]   [Full Text] [Related]  

  • 74. Fatal Hemophilus influenzae sepsis in an asymptomatic splenectomized Hodgkin's disease patient.
    Nixon DW; Aisenberg AC
    Ann Intern Med; 1972 Jul; 77(1):69-71. PubMed ID: 4538209
    [No Abstract]   [Full Text] [Related]  

  • 75. The incidence of post-splenectomy sepsis and herpes zoster in children and adolescents with Hodgkin disease.
    Green DM; Stutzman L; Blumenson LE; Brecher ML; Thomas PR; Allen JE; Jewett TC; Freeman AI
    Med Pediatr Oncol; 1979; 7(3):285-97. PubMed ID: 317350
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Specific antibacterial antibody-producing cells in human nasal mucosa.
    Béné MC; Faure G; Wayoff M
    Adv Exp Med Biol; 1987; 216A():369-73. PubMed ID: 3318287
    [No Abstract]   [Full Text] [Related]  

  • 77. Haemophilus influenzae diphtheria protein conjugate immunization after therapy in splenectomized patients with Hodgkin disease.
    Jakacki R; Luery N; McVerry P; Lange B
    Ann Intern Med; 1990 Jan; 112(2):143-4. PubMed ID: 2294819
    [No Abstract]   [Full Text] [Related]  

  • 78. Conjugated Haemophilus influenzae type b vaccine.
    Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
    [No Abstract]   [Full Text] [Related]  

  • 79. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccine.
    Pediatrics; 1988 Jun; 81(6):908-11. PubMed ID: 3259309
    [No Abstract]   [Full Text] [Related]  

  • 80. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jan; 37(2):13-6. PubMed ID: 3122004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.